Jeff Poulton

About Jeff Poulton

Jeff Poulton is a director at CervoMed.

Form D filings name Jeff Poulton as a director at EIP Pharma.

Jeff Poulton reports to the SEC as a director or officer of 3 public companies, including Alnylam Pharmaceuticals (ALNY) and Q32 Bio (QTTB).

Jeff Poulton first appears on SEC filings in 2018.

Experience

This experience comes from SEC filings. The years are when the filings name Jeff Poulton in the role, so the role may have started earlier or lasted longer.

Key Colleagues at Startups

The people Jeff Poulton works with at each company, as listed on that company's latest Form D.

Sources

1. SECEIP Pharma, Inc. Form D, filed Jul 20, 2023
2. SECForms 3, 4 and 5 filed by Jeff Poulton (SEC filer 1782962)